Mainstream

Pulmonx revises 2025 revenue target to $90M–$92M as U.S. initiatives ramp slower, while international growth accelerates

Pulmonx revises 2025 revenue target to $90M–$92M as U.S. initiatives ramp slower, while international growth accelerates

Post ContentlungRead More

You might also be interested in reading Enphase cut at Truist, with growth headwinds persisting for next several quarters.

July 31, 2025
In Mainstream